1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Kowa Pharmaceuticals

Anonymous board for Kowa Pharmaceuticals


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    15
    Views:
    6,363
  2. anonymous
    Replies:
    10
    Views:
    703
  3. anonymous
    Replies:
    0
    Views:
    476
  4. anonymous
    Replies:
    7
    Views:
    1,290
  5. anonymous
    Replies:
    2
    Views:
    543
  6. anonymous
    Replies:
    1
    Views:
    483
  7. anonymous
    Replies:
    9
    Views:
    2,621
  8. anonymous
    Replies:
    0
    Views:
    688
  9. anonymous
    Replies:
    4
    Views:
    1,230
  10. anonymous
    Replies:
    26
    Views:
    5,492
  11. anonymous
    Replies:
    9
    Views:
    6,612
  12. anonymous
    Replies:
    4
    Views:
    2,838
  13. anonymous
    Replies:
    2
    Views:
    1,833
  14. anonymous
    Replies:
    2
    Views:
    1,515
  15. anonymous
    Replies:
    1
    Views:
    1,843
  16. anonymous
    Replies:
    14
    Views:
    3,205
  17. anonymous
    Replies:
    2
    Views:
    2,209
  18. anonymous
    Replies:
    13
    Views:
    5,505
  19. Anonymous
    Replies:
    7
    Views:
    7,474
  20. anonymous
    Replies:
    1
    Views:
    1,825

Thread Display Options

Loading...